2027 General Election:
-- d-- h-- m-- sSee Politics Coverage →
In Other News · Kenya
Phase‑3 trial shows solengeprase cuts daily “off” time for Parkinson’s patients
Source: Kenya Today
Summary
In a 12‑week Phase 3 study, the experimental pill solengeprase reduced daily off‑time by up to 37 minutes and added roughly 36 minutes of dyskinesia‑free movement.
Continue reading on Kenya Today →
You'll be taken to kenya-today.com
← Back to In Other News
↑
Customize
Reject All
Accept All
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None
Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
None